- Report
- September 2024
- 142 Pages
Global
From €2662EUR$2,999USD£2,291GBP
- Report
- March 2025
- 96 Pages
Global
From €3500EUR$4,224USD£3,118GBP
- Report
- February 2024
- 185 Pages
Global
From €3994EUR$4,500USD£3,438GBP
- Report
- April 2024
- 87 Pages
From €3062EUR$3,450USD£2,636GBP
- Report
- April 2024
- 106 Pages
Asia Pacific
From €3062EUR$3,450USD£2,636GBP
- Report
- August 2024
- 200 Pages
Global
From €4393EUR$4,949USD£3,781GBP
- Report
- August 2023
- 94 Pages
Global
From €3500EUR$4,224USD£3,118GBP
The Intramuscular Injection market is a subset of the Infusions and Injectables market. Intramuscular injections are a type of medical procedure in which a drug is injected directly into a muscle. This type of injection is used to deliver medications that cannot be taken orally, such as vaccines, hormones, and antibiotics. Intramuscular injections are also used to deliver medications that require a rapid onset of action, such as anesthetics.
Intramuscular injections are typically administered by a healthcare professional, such as a doctor or nurse. The injection is usually given in the upper arm, thigh, or buttocks. The injection site is typically cleaned with an antiseptic solution prior to the injection.
The Intramuscular Injection market is highly competitive, with many companies offering a variety of products and services. Some of the major players in the market include Pfizer, Merck, Sanofi, Novartis, and GlaxoSmithKline. Show Less Read more